By restoring cellular methyl donor capacity, it may support genomic stability and longevity-associated gene expression patterns
They target the same outcome (tissue repair) through different mechanisms : BPC-157: local growth factor expression, fibroblast stimulation, angiogenesis at the injury site TB-500: systemic cell migration, actin regulation, reduction of chronic inflammation throughout the body Standard Wolverine stack: BPC-157: 250500 mcg SC twice daily , injected near the injury site where possible TB-500: 22.5 mg SC twice weekly loading (weeks 14), then 2 mg weekly maintenance (weeks 512) CRITICAL: do not mix in the same vial - they can be injected in the same session but must remain in separate solutions
Below 5mg/mL, oxidative degradation accelerates due to increased air-peptide surface contact
Haggerty KL, Campetti R, Stoeckle RJ, EpsteinLubow G, Evertson LC, Spragens L